China Companion Animal Health Market

The China companion animal health market, worth USD 1.3 Bn, is boosted by urbanization, pet humanization, and government regulations, projecting robust growth through innovative products and online sales.

Region:Asia

Author(s):Dev

Product Code:KRAA1658

Pages:81

Published On:August 2025

About the Report

Base Year 2024

China Companion Animal Health Market Overview

  • The China Companion Animal Health Market is valued at USD 1.3 billion, based on a five-year historical analysis. This value reflects rising pet ownership, higher disposable incomes in urban households, and greater awareness of preventive pet healthcare, which together are increasing demand for veterinary services, pharmaceuticals, vaccines, and diagnostics.
  • Key cities dominating the market include Beijing, Shanghai, and Guangzhou, driven by urbanization, high pet ownership density, and concentration of veterinary service infrastructure and pet specialty retail; China’s urban pet spend has grown with pet humanization and middle?class expansion, reinforcing these hubs as focal points for premium services and products.
  • In recent years, the Chinese government has strengthened animal health governance through revisions to the Animal Epidemic Prevention Law, which stipulates mandatory rabies vaccination for dogs and strengthened health monitoring and quarantine measures to mitigate zoonotic risks and improve companion animal health standards.
China Companion Animal Health Market Size

China Companion Animal Health Market Segmentation

By Type:The market is segmented into various types, including pharmaceuticals, vaccines, diagnostics, nutritional supplements, veterinary services, veterinary software & devices, pet insurance, and others. Among these, pharmaceuticals, particularly therapeutics, dominate the market due to the increasing prevalence of pet diseases, rising urban pet populations, and a growing focus on preventive healthcare; demand for vaccines remains significant as dog and cat immunization adherence increases via clinics and organized hospital networks.

China Companion Animal Health Market segmentation by Type.

By End-User:The end-user segmentation includes veterinary clinics, animal hospitals, diagnostic laboratories, pet owners (DTC/e-commerce purchase), and pet retailers & pharmacies. Veterinary clinics and animal hospitals remain the primary end?users as they deliver core vaccination, anti-parasitic, surgical, and diagnostic services; e?commerce expansion (including brand flagship stores) enables direct purchase of OTC preventives, diets, and certain diagnostics by pet owners, supporting overall market growth.

China Companion Animal Health Market segmentation by End-User.

China Companion Animal Health Market Competitive Landscape

The China Companion Animal Health Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health (MSD Animal Health), Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Virbac, IDEXX Laboratories, Mindray Animal Medical (Shenzhen Mindray Bio?Medical Electronics Co., Ltd.), Sinopharm Animal Health (China National Pharmaceutical Group), Jiangsu Ringpu Bio-Technology Co., Ltd. (Ringpu), JINYU Bio-Technology Co., Ltd. (China Animal Husbandry Group), Qilu Animal Health Products Co., Ltd., New Ruipeng Group (NRP Group) – Veterinary Services, Pidu Biotechnology Co., Ltd. (Shanghai Pidu Bio) – Companion Diagnostics/OTC, Thermo Fisher Scientific – Veterinary Diagnostics & Reagents contribute to innovation, geographic expansion, and service delivery in this space.

Zoetis Inc.

1952

Parsippany-Troy Hills, New Jersey, USA

Merck Animal Health

1891

Rahway, New Jersey, USA

Elanco Animal Health

1954

Greenfield, Indiana, USA

Boehringer Ingelheim Animal Health

1885

Ingelheim am Rhein, Germany

Ceva Santé Animale

1999

Libourne, France

Company

Establishment Year

Headquarters

China Companion-Animal Revenue (latest fiscal, USD/CNY)

3?Year CAGR in China Companion Segment

Portfolio Breadth (therapeutics, vaccines, diagnostics, services, software; count of SKUs/modalities)

Regulatory Approvals in China (NMPA/MAA or MARA registrations, last 3 years)

Distribution Reach (cities covered, clinic/hospital accounts, e?commerce flagship presence)

Pricing Positioning (premium/mid/economy; average list price index vs market =100)

China Companion Animal Health Market Industry Analysis

Growth Drivers

  • Increasing Pet Ownership:The number of pet owners in China has surged, with over 60 million households owning pets as of now. This trend is driven by urbanization and changing lifestyles, leading to a projected increase in pet ownership by 10 million households in the future. The growing affection for pets is reflected in the rising demand for health products and services, which is expected to reach approximately 200 billion CNY in the future, highlighting the market's potential.
  • Rising Disposable Income:China's per capita disposable income reached 39,218 CNY, marking nominal growth from the previous year. This rise in income allows pet owners to spend more on premium pet health products and services. In the future, it is anticipated that spending on companion animal health will increase by 15%, driven by consumers' willingness to invest in quality veterinary care and health products, thus enhancing overall market growth.
  • Growing Awareness of Pet Health:Awareness regarding pet health has significantly increased, with 70% of pet owners now prioritizing regular veterinary check-ups. This shift is supported by educational campaigns and the rise of social media, which have informed pet owners about preventive care. In the future, the demand for preventive health services is expected to grow by 20%, reflecting a cultural shift towards responsible pet ownership and proactive health management.

Market Challenges

  • Regulatory Compliance Issues:The companion animal health sector in China faces stringent regulatory compliance challenges, particularly concerning veterinary drug regulations. Currently, over 30% of veterinary businesses reported difficulties in adhering to these regulations, which can lead to delays in product launches and increased operational costs. This regulatory landscape poses a significant barrier to market entry for new players and can stifle innovation within the industry.
  • High Competition Among Players:The companion animal health market is characterized by intense competition, with over 1,000 registered veterinary clinics and numerous product manufacturers. This saturation leads to price wars, which can erode profit margins. Currently, the average profit margin for veterinary services was reported at only 10%, making it challenging for businesses to sustain growth. Companies must differentiate themselves through quality and innovation to remain competitive in this crowded market.

China Companion Animal Health Market Future Outlook

The future of the China companion animal health market appears promising, driven by increasing pet ownership and a growing focus on pet wellness. As disposable incomes rise, consumers are expected to invest more in premium health products and services. Additionally, the integration of technology in veterinary practices, such as telemedicine and health monitoring apps, will enhance service delivery. These trends indicate a robust growth trajectory, with significant opportunities for innovation and expansion in the coming years.

Market Opportunities

  • Growth in E-commerce for Pet Products:The e-commerce sector for pet products is projected to grow significantly, with online sales expected to reach 50 billion CNY in the future. This growth is driven by the convenience of online shopping and the increasing number of pet owners seeking quality products. Companies that invest in e-commerce platforms can tap into this expanding market, enhancing their reach and customer engagement.
  • Development of Innovative Health Products:There is a rising demand for innovative health products, including supplements and organic food, with the market for organic pet food projected to grow to 15 billion CNY in the future. This trend reflects pet owners' increasing focus on health and wellness. Companies that prioritize research and development in this area can capitalize on the growing consumer preference for high-quality, health-oriented pet products.

Scope of the Report

SegmentSub-Segments
By Type

Pharmaceuticals (Therapeutics: parasiticides, anti-infectives, pain & anti-inflammatory, dermatology, cardiometabolic, others)

Vaccines (core and non-core for dogs & cats)

Diagnostics (in?clinic analyzers, rapid tests, imaging, molecular & immunodiagnostics)

Nutritional Supplements (probiotics, joint/omega, vitamins & minerals)

Veterinary Services (preventive care, surgery, hospitalization, tele?vet)

Veterinary Software & Devices (practice management, AI imaging, wearables)

Pet Insurance

Others (grooming/OTC wellness)

By End-User

Veterinary Clinics

Animal Hospitals

Diagnostic Laboratories

Pet Owners (DTC/e-commerce purchase)

Pet Retailers & Pharmacies

By Distribution Channel

Veterinary Channel (clinic/hospital dispensing)

Online Retail & Marketplaces (Tmall, JD, WeChat mini?programs)

Pet Specialty Stores & Pharmacies

Supermarkets/Hypermarkets

Company Direct & B2B Distributors

By Product Formulation

Tablets/Chews

Liquids/Suspensions

Injectables

Topicals

Powders/Granules

By Animal Type

Dogs

Cats

Small Mammals (rabbits, guinea pigs)

Birds & Others

By Price Range

Premium

Mid-range

Economy

By Region

North China (Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia)

East China (Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, Shandong)

South & Central China (Guangdong, Guangxi, Hainan, Hunan, Hubei, Henan)

Southwest China (Sichuan, Chongqing, Yunnan, Guizhou, Tibet)

Northwest China (Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang)

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Agriculture and Rural Affairs, National Health Commission)

Manufacturers and Producers

Distributors and Retailers

Veterinary Clinics and Animal Hospitals

Pet Food and Supplement Companies

Animal Health Product Suppliers

Insurance Companies Offering Pet Health Insurance

Players Mentioned in the Report:

Zoetis Inc.

Merck Animal Health (MSD Animal Health)

Elanco Animal Health

Boehringer Ingelheim Animal Health

Ceva Sante Animale

Virbac

IDEXX Laboratories

Mindray Animal Medical (Shenzhen Mindray BioMedical Electronics Co., Ltd.)

Sinopharm Animal Health (China National Pharmaceutical Group)

Jiangsu Ringpu Bio-Technology Co., Ltd. (Ringpu)

JINYU Bio-Technology Co., Ltd. (China Animal Husbandry Group)

Qilu Animal Health Products Co., Ltd.

New Ruipeng Group (NRP Group) Veterinary Services

Pidu Biotechnology Co., Ltd. (Shanghai Pidu Bio) Companion Diagnostics/OTC

Thermo Fisher Scientific Veterinary Diagnostics & Reagents

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. China Companion Animal Health Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 China Companion Animal Health Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. China Companion Animal Health Market Analysis

3.1 Growth Drivers

3.1.1 Increasing Pet Ownership
3.1.2 Rising Disposable Income
3.1.3 Growing Awareness of Pet Health
3.1.4 Expansion of Veterinary Services

3.2 Market Challenges

3.2.1 Regulatory Compliance Issues
3.2.2 High Competition Among Players
3.2.3 Limited Access to Veterinary Care in Rural Areas
3.2.4 Price Sensitivity Among Pet Owners

3.3 Market Opportunities

3.3.1 Growth in E-commerce for Pet Products
3.3.2 Development of Innovative Health Products
3.3.3 Increasing Demand for Organic Pet Food
3.3.4 Expansion into Tier 2 and Tier 3 Cities

3.4 Market Trends

3.4.1 Rise of Pet Insurance
3.4.2 Increasing Focus on Preventive Care
3.4.3 Integration of Technology in Veterinary Services
3.4.4 Growth of Pet Wellness Products

3.5 Government Regulation

3.5.1 Animal Health Law Compliance
3.5.2 Veterinary Drug Regulations
3.5.3 Import and Export Regulations for Animal Products
3.5.4 Animal Welfare Standards

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. China Companion Animal Health Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. China Companion Animal Health Market Segmentation

8.1 By Type

8.1.1 Pharmaceuticals (Therapeutics: parasiticides, anti-infectives, pain & anti-inflammatory, dermatology, cardiometabolic, others)
8.1.2 Vaccines (core and non-core for dogs & cats)
8.1.3 Diagnostics (in?clinic analyzers, rapid tests, imaging, molecular & immunodiagnostics)
8.1.4 Nutritional Supplements (probiotics, joint/omega, vitamins & minerals)
8.1.5 Veterinary Services (preventive care, surgery, hospitalization, tele?vet)
8.1.6 Veterinary Software & Devices (practice management, AI imaging, wearables)
8.1.7 Pet Insurance
8.1.8 Others (grooming/OTC wellness)

8.2 By End-User

8.2.1 Veterinary Clinics
8.2.2 Animal Hospitals
8.2.3 Diagnostic Laboratories
8.2.4 Pet Owners (DTC/e-commerce purchase)
8.2.5 Pet Retailers & Pharmacies

8.3 By Distribution Channel

8.3.1 Veterinary Channel (clinic/hospital dispensing)
8.3.2 Online Retail & Marketplaces (Tmall, JD, WeChat mini?programs)
8.3.3 Pet Specialty Stores & Pharmacies
8.3.4 Supermarkets/Hypermarkets
8.3.5 Company Direct & B2B Distributors

8.4 By Product Formulation

8.4.1 Tablets/Chews
8.4.2 Liquids/Suspensions
8.4.3 Injectables
8.4.4 Topicals
8.4.5 Powders/Granules

8.5 By Animal Type

8.5.1 Dogs
8.5.2 Cats
8.5.3 Small Mammals (rabbits, guinea pigs)
8.5.4 Birds & Others

8.6 By Price Range

8.6.1 Premium
8.6.2 Mid-range
8.6.3 Economy

8.7 By Region

8.7.1 North China (Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia)
8.7.2 East China (Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, Shandong)
8.7.3 South & Central China (Guangdong, Guangxi, Hainan, Hunan, Hubei, Henan)
8.7.4 Southwest China (Sichuan, Chongqing, Yunnan, Guizhou, Tibet)
8.7.5 Northwest China (Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang)

9. China Companion Animal Health Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 China Companion-Animal Revenue (latest fiscal, USD/CNY)
9.2.3 3?Year CAGR in China Companion Segment
9.2.4 Portfolio Breadth (therapeutics, vaccines, diagnostics, services, software; count of SKUs/modalities)
9.2.5 Regulatory Approvals in China (NMPA/MAA or MARA registrations, last 3 years)
9.2.6 Distribution Reach (cities covered, clinic/hospital accounts, e?commerce flagship presence)
9.2.7 Pricing Positioning (premium/mid/economy; average list price index vs market =100)
9.2.8 Local Manufacturing/Localization Level (imported vs JV/contract manufacturing; localization ratio %)
9.2.9 Key Partnerships (distributors, vet chains, platforms; count and notables)
9.2.10 Brand Awareness Among Pet Owners/Vets (survey index or social/search mentions)
9.2.11 After?sales & Technical Support Coverage (install base support for analyzers; response SLAs)
9.2.12 Innovation Intensity (R&D spend %, China launches, AI/diagnostics capabilities)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Zoetis Inc.
9.5.2 Merck Animal Health (MSD Animal Health)
9.5.3 Elanco Animal Health
9.5.4 Boehringer Ingelheim Animal Health
9.5.5 Ceva Santé Animale
9.5.6 Virbac
9.5.7 IDEXX Laboratories
9.5.8 Mindray Animal Medical (Shenzhen Mindray Bio?Medical Electronics Co., Ltd.)
9.5.9 Sinopharm Animal Health (China National Pharmaceutical Group)
9.5.10 Jiangsu Ringpu Bio-Technology Co., Ltd. (Ringpu)
9.5.11 JINYU Bio-Technology Co., Ltd. (China Animal Husbandry Group)
9.5.12 Qilu Animal Health Products Co., Ltd.
9.5.13 New Ruipeng Group (NRP Group) – Veterinary Services
9.5.14 Pidu Biotechnology Co., Ltd. (Shanghai Pidu Bio) – Companion Diagnostics/OTC
9.5.15 Thermo Fisher Scientific – Veterinary Diagnostics & Reagents

10. China Companion Animal Health Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Animal Health
10.1.2 Decision-Making Processes
10.1.3 Supplier Selection Criteria

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Veterinary Facilities
10.2.2 Spending on Pet Health Initiatives

10.3 Pain Point Analysis by End-User Category

10.3.1 Access to Quality Veterinary Care
10.3.2 Affordability of Pet Health Products
10.3.3 Availability of Specialized Services

10.4 User Readiness for Adoption

10.4.1 Awareness of Health Products
10.4.2 Willingness to Pay for Premium Services

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Evaluation of Health Outcomes
10.5.2 Long-term Cost Savings

11. China Companion Animal Health Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from veterinary associations and pet health organizations
  • Review of government publications on pet ownership statistics and health regulations
  • Examination of market trends through academic journals and white papers on companion animal health

Primary Research

  • Interviews with veterinarians and pet health professionals to gather insights on treatment trends
  • Surveys with pet owners to understand purchasing behavior and health concerns
  • Focus groups with pet product manufacturers to discuss market challenges and innovations

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including sales data and consumer surveys
  • Triangulation of insights from veterinary professionals, pet owners, and industry reports
  • Sanity checks conducted through expert panel reviews to ensure data accuracy

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on national pet ownership statistics and average spending per pet
  • Segmentation of the market by product categories such as pharmaceuticals, supplements, and preventive care
  • Incorporation of growth rates from historical data and projected trends in pet ownership

Bottom-up Modeling

  • Collection of sales data from leading pet health product manufacturers and retailers
  • Estimation of market share based on product distribution channels and regional sales performance
  • Volume x price analysis to derive revenue estimates for each product segment

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating variables such as economic growth, pet ownership trends, and health awareness
  • Scenario modeling based on potential regulatory changes and shifts in consumer preferences
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Clinics150Veterinarians, Clinic Managers
Pet Owners140Dog and Cat Owners, Pet Care Enthusiasts
Pet Product Retailers100Store Managers, Product Buyers
Pet Health Product Manufacturers80Product Development Managers, Marketing Directors
Animal Health Researchers60Research Scientists, Academic Professionals

Frequently Asked Questions

What is the current value of the China Companion Animal Health Market?

The China Companion Animal Health Market is valued at approximately USD 1.3 billion, reflecting a significant increase in demand for veterinary services, pharmaceuticals, vaccines, and diagnostics due to rising pet ownership and disposable incomes in urban households.

What factors are driving growth in the China Companion Animal Health Market?

Which cities are the main hubs for the China Companion Animal Health Market?

What are the main segments of the China Companion Animal Health Market?

Other Regional/Country Reports

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022